Bortezomib, melphalan, and prednisone in elderly relapsed/refractory multiple myeloma patients: update of multicenter, open-label Phase 1/2 study

被引：2
作者：
Grammatico, Sara [1 ]
Bringhen, Sara [2 ]
Vozella, Federico [1 ]
Siniscalchi, Agostina [3 ]
Boccadoro, Mario [2 ]
Petrucci, Maria Teresa [1 ]
机构：
[1] Sapienza Univ, Dept Cellular Biotechnol & Hematol, Hematol Serv, Rome, Italy
[2] Univ Torino, Dept Hematol, Turin, Italy
[3] S Eugenio Hosp, Dept Hematol, Rome, Italy
来源：
LEUKEMIA & LYMPHOMA | 2017年 / 58卷 / 11期
关键词：
INITIAL TREATMENT; FOLLOW-UP; DEXAMETHASONE; TRIAL; LENALIDOMIDE; REGIMENS; EFFICACY; THERAPY;
D O I：
10.1080/10428194.2017.1307360
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2738 / 2740
页数：3
相关论文
共 15 条
[1]   Safety and efficacy of bortezomib and melphalan combination in patients with relapsed or refractory multiple myeloma: updated results of a phase 1/2 study after longer follow-up [J].
Berenson, James R. ;
Yang, Hank H. ;
Vescio, Robert A. ;
Nassir, Youram ;
Mapes, Russell ;
Lee, Shi-pyng ;
Wilson, Joanna ;
Yellin, Ori ;
Morrison, Blake ;
Hilger, Jacqueline ;
Swift, Regina .
ANNALS OF HEMATOLOGY, 2008, 87 (08) :623-631
[2]   Phase I/II trial assessing bortezomlb and melphalan combination therapy for the treatment of patients with relapsed or refractory multiple myeloma [J].
Berenson, JR ;
Yang, HH ;
Sadler, K ;
Jarutirasarn, SG ;
Vescio, RA ;
Mapes, R ;
Purner, M ;
Lee, SP ;
Wilson, J ;
Morrison, B ;
Adams, J ;
Schenkein, D ;
Swift, R .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (06) :937-944
[3]   Salvage therapy with bortezomib and dexamethasone in elderly patients with relapsed/refractory multiple myeloma [J].
Castelli, Roberto ;
Pantaleo, Giuseppe ;
Gallipoli, Paolo ;
Gidaro, Antonio ;
Arquati, Massimo ;
Wu, Maddalena A. ;
Deliliers, Giorgio Lambertenghi .
ANTI-CANCER DRUGS, 2015, 26 (10) :1078-1082
[4]   Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma [J].
Dimopoulos, Meletios ;
Spencer, Andrew ;
Attal, Michael ;
Prince, H. Miles ;
Harousseau, Jean-Luc ;
Dmoszynska, Anna ;
San Miguel, Jesus ;
Hellmann, Andrzej ;
Facon, Thierry ;
Foa, Robin ;
Corso, Alessandro ;
Masliak, Zvenyslava ;
Olesnyckyj, Marta ;
Yu, Zhinuan ;
Patin, John ;
Zeldis, Jerome B. ;
Knight, Robert D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21) :2123-2132
[5]   Bortezomib cumulative dose, efficacy, and tolerability with three different bortezomib-melphalan-prednisone regimens in previously untreated myeloma patients ineligible for high-dose therapy [J].
Mateos, Maria-Victoria ;
Bringhen, Sara ;
Richardson, Paul G. ;
Jose Lahuerta, Juan ;
Larocca, Alessandra ;
Oriol, Albert ;
Boccadoro, Mario ;
Garcia-Sanz, Ramon ;
Di Raimondo, Francesco ;
Esseltine, Dixie-Lee ;
van de Velde, Helgi ;
Desai, Avinash ;
Londhe, Anil ;
San Miguel, Jesus F. ;
Palumbo, Antonio .
HAEMATOLOGICA, 2014, 99 (06) :1114-1122
[6]   Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial [J].
Mateos, Maria-Victoria ;
Oriol, Albert ;
Martinez-Lopez, Joaquin ;
Gutierrez, Norma ;
Teruel, Ana-Isabel ;
de Paz, Raquel ;
Garcia-Larana, Jose ;
Bengoechea, Enrique ;
Martin, Alejandro ;
Diaz Mediavilla, Joaquin ;
Palomera, Luis ;
de Arriba, Felipe ;
Gonzalez, Yolanda ;
Hernandez, Jose-Mariano ;
Sureda, Ana ;
Bello, Jose-Luis ;
Bargay, Joan ;
Penalver, Francisco-Javier ;
Ribera, Jose-Maria ;
Martin-Mateos, Maria-Luisa ;
Garcia-Sanz, Ramon ;
Cibeira, Maria-Teresa ;
Martin Ramos, Maria-Luisa ;
Vidriales, Maria-Belen ;
Paiva, Bruno ;
Montalban, Maria-Angeles ;
Lahuerta, Juan-Jose ;
Blade, Joan ;
San Miguel, Jesus-Fernando .
LANCET ONCOLOGY, 2010, 11 (10) :934-941
[7]   Community-Based Phase IIIB Trial of Three UPFRONT Bortezomib-Based Myeloma Regimens [J].
Niesvizky, Ruben ;
Flinn, Ian W. ;
Rifkin, Robert ;
Gabrail, Nashat ;
Charu, Veena ;
Clowney, Billy ;
Essell, James ;
Gaffar, Yousuf ;
Warr, Thomas ;
Neuwirth, Rachel ;
Zhu, Yanyan ;
Elliott, Jennifer ;
Esseltine, Dixie-Lee ;
Niculescu, Liviu ;
Reeves, James .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (33) :3921-+
[8]   Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: A Randomized Controlled Trial [J].
Palumbo, Antonio ;
Bringhen, Sara ;
Rossi, Davide ;
Cavalli, Maide ;
Larocca, Alessandra ;
Ria, Roberto ;
Offidani, Massimo ;
Patriarca, Francesca ;
Nozzoli, Chiara ;
Guglielmelli, Tommasina ;
Benevolo, Giulia ;
Callea, Vincenzo ;
Baldini, Luca ;
Morabito, Fortunato ;
Grasso, Mariella ;
Leonardi, Giovanna ;
Rizzo, Manuela ;
Falcone, Antonietta Pia ;
Gottardi, Daniela ;
Montefusco, Vittorio ;
Musto, Pellegrino ;
Petrucci, Maria Teresa ;
Ciccone, Giovannino ;
Boccadoro, Mario .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (34) :5101-5109
[9]   Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma [J].
Palumbo, Antonio ;
Dimopoulos, Meletios ;
San Miguel, Jesus ;
Harousseau, Jean-Luc ;
Attal, Michel ;
Hussein, Mohamad ;
Knop, Stefan ;
Ludwig, Heinz ;
von Lilienfeld-Toal, Marie ;
Sonneveld, Pieter .
BLOOD REVIEWS, 2009, 23 (02) :87-93
[10]   A prospective, international phase 2 study of bortezomib retreatment in patients with relapsed multiple myeloma [J].
Petrucci, Maria T. ;
Giraldo, Pilar ;
Corradini, Paolo ;
Teixeira, Adriana ;
Dimopoulos, Meletios A. ;
Blau, Igor W. ;
Drach, Johannes ;
Angermund, Ralf ;
Allietta, Nathalie ;
Broer, Esther ;
Mitchell, Vivien ;
Blade, Joan .
BRITISH JOURNAL OF HAEMATOLOGY, 2013, 160 (05) :649-659
12